Sensex and Nifty: A Flat Session with Underlying Strength

The BSE Sensex opened the day flat, dipping slightly by 45.26 points in early trade but stabilising to close with a negligible loss of 6.36 points, or 0.01%, at 77,094.11. Despite the lacklustre session, the index remains above its 50-day moving average (DMA), signalling underlying resilience. However, the 50DMA itself continues to trade below the 200DMA, indicating a longer-term consolidation phase.

Over the past three weeks, the Sensex has gained a robust 3.84%, reflecting steady accumulation amid global uncertainties. The Nifty mirrored this trend, with the pharmaceutical sector (NIFTYPHARMA) leading gains, advancing 1.86% and marking new 52-week highs alongside the S&P BSE Healthcare index.

Sectoral Performance: Pharma Leads, Auto Trails

Out of 38 sectors tracked today, 12 advanced while 26 declined, underscoring a broad-based market hesitation. The pharmaceutical sector was the standout performer, buoyed by strong buying interest and positive sentiment around healthcare stocks. In contrast, the auto sector lagged, falling 1.35%, weighed down by profit-booking and subdued demand outlooks.

Other sectors showed mixed fortunes, with large caps trading largely flat. The BSE100 large-cap index slipped 0.07%, the S&P BSE 150 Midcap index declined 0.31%, and the S&P BSE 250 Smallcap index fell 0.40%, reflecting a cautious stance among investors across market capitalisation segments.

Top Gainers and Losers: Divergence Across Market Caps

Among large caps, Dr Reddy's Laboratories led the gainers with a 4.04% rise, supported by robust fundamentals and sector tailwinds. Midcap stocks saw Hexaware Technologies surge 6.83%, while small caps were led by Zydus Wellness with a 6.10% gain, both reflecting selective buying in quality names.

On the downside, Persistent Systems was the top loser across large and midcap segments, plunging 9.79% amid profit-taking and cautious outlooks. Small caps were dragged lower by Netweb Technologies, which declined 7.84%, while Astral also saw a sharp 8.58% fall, signalling sector-specific pressures.

Market Breadth and Volume: Signs of Caution

The advance-decline ratio across the BSE500 index stood at 0.61x, with 188 advances against 309 declines, indicating a market breadth skewed towards sellers. This breadth weakness was consistent with the marginal declines in mid and small-cap indices, suggesting investors preferred to stay on the sidelines or book profits in riskier segments.

Trading volumes remained moderate, with no significant spikes, reflecting a wait-and-watch approach ahead of key corporate earnings and global cues.

Foreign Institutional Investors and Domestic Activity

Foreign institutional investors (FIIs) remained cautious, with subdued buying interest observed in the session. Domestic institutional investors (DIIs) also showed restrained activity, reflecting a wait-and-watch stance amid mixed global cues. This lack of decisive institutional participation contributed to the muted market movement.

Global markets were mixed, with US indices consolidating after recent gains and Asian markets showing modest declines. The cautious global backdrop, combined with domestic macroeconomic factors, influenced investor sentiment, resulting in a balanced but hesitant market environment.

Technical Outlook and Key Levels

Technically, the Sensex holding above its 50DMA is a positive sign, suggesting that short-term momentum remains intact. However, the 50DMA trading below the 200DMA indicates that the broader trend is still in a consolidation phase, requiring confirmation through sustained buying above key resistance levels.

Investors should watch for sector rotation, particularly whether the pharmaceutical sector can maintain its leadership and if the auto sector can stabilise after recent declines. The upcoming quarterly results, including that of CMR Green Tech scheduled for 30th June 2026, will be closely monitored for cues on earnings momentum.

Summary and Investor Takeaways

In summary, the Indian equity market exhibited a cautious tone on 29 June 2026, with the Sensex closing flat amid mixed sectoral performances. The pharmaceutical sector’s strength provided a bright spot, reaching new highs and signalling investor preference for defensive and growth-oriented stocks. Conversely, the auto sector’s weakness highlighted ongoing challenges in discretionary spending and demand outlooks.

Market breadth and institutional activity suggested a lack of conviction, with investors awaiting clearer signals from upcoming earnings and global developments. The technical setup points to a consolidation phase, where selective stock picking and sectoral focus will be key to navigating the market.

Investors are advised to monitor the evolving macroeconomic environment, corporate earnings, and global cues closely, while maintaining a balanced portfolio approach that favours quality and growth sectors such as pharmaceuticals.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →